Table 2.
Clinical characteristics of 139 people experiencing homelessness with RT-PCR confirmed SARS-CoV-2 infection admitted to the isolation facility.
| Clinical characteristics | % (n/N)1 |
|---|---|
| Symptomatic | 80.9% (114/141) |
| Asymptomatic | 19.1% (27/141) |
| Duration of symptoms | Median [Range] 5.0 [1.0–26.0] |
| Reported symptoms | |
| Cough | 58.9% (83/141) |
| Rhinorrhea | 54.6% (77/141) |
| Myalgia | 12.8% (18/141) |
| Headache | 45.4% (64/141) |
| Gastrointestinal | 14.9% (21/141) |
| Sore throat | 16.3% (23/141) |
| Shortness of breath | 11.3% (16/141) |
| Loss of smell and/or taste | 9.9% (14/141) |
| Others | 19.1% (27/141) |
| Fever (>38°C) | 2.8% (4/141) |
| SpO2 < 95% | 32.6% (46/141) |
| SpO2 < 90% | 5% (7/141) |
| Other medical conditions during stay | 80% (113/141) |
| Hypertension Grade 1 | 29.1% (41/141) |
| Hypertension Grade 2 | 19.9% (28/141) |
| Hypertension Grade 3 | 10.6% (15/141) |
| Withdrawal symptoms | 15.6% (22/141) |
| Musculosceletal conditions | 9.9% (14/141) |
| Urogenital diseases | 4.3% (6/141) |
| Sleeping disorders | 8.5% (12/141) |
| Dermatological conditions | 14.2% (20/141) |
| Staff-observed psychological distress | 19.9% (28/141) |
| Wound management | 12.8% (18/141) |
| Others | 16.3% (23/141) |
| Hospitalization | 8.5% (12/141) |
| Hospitalization due to COVID-19 progression | 2.1% (3/141) |
| Hospitalization due to COVID-19 progression | 6.4% (9/141) |
| Specialized outpatient medical care | 2.8% (4/141) |
1
Clinical characteristics of 139 individual patients. Two individuals were admitted twice with an assumed reinfection, resulting in a number of N = 141 clinical observations.